Efficacy of 5% tranexamic acid in melasma

Authors

  • Faisal Ramzan Department of Dermatology, AIMC/ Jinnah Hospital, Lahore.
  • Khadija Malik Department of Dermatology, AIMC/ Jinnah Hospital, Lahore.
  • Bushra Bashir Department of Dermatology, AIMC/ Jinnah Hospital, Lahore.
  • Zaeema Naseer
  • Atif Shehzad Department of Dermatology, AIMC/ Jinnah Hospital, Lahore.
  • Lamees Malik Department of Dermatology, AIMC/ Jinnah Hospital, Lahore.
  • Tariq Rashid

Keywords:

Tranexamic acid, Melasma

Abstract

Melasma is common acquired hyper -melanosis of sun-exposed skin, and is seen frequently in individuals with darker skin type thus causing considerable cosmetic disfigurement. The exact cause of melasma is unknown but multiple factors are implicated in its etiopathogenesis, mainly ultraviolet light exposure, pregnancy, iron deficiency and oral contraceptive use. Treatment of melasma has generally been difficult. Tranexamic acid has been used in dermatology for the improvement of melasma. Objective To determine the efficacy of topical 5% tranexamic acid cream in patients of melasma Material & Methods:  Total 100 patients of either gender with clinical diagnosis of melasma were enrolled in the study after taking informed written consent. The demographic data was collected on a pre-designed proforma. Baseline modified MASI score was calculated and pictures were taken of all patients at baseline. The patients were advised to apply 5% topical tranexamic acid cream at night along with sunscreen during day time for 12 weeks daily. All patients were evaluated for improvement of melasma using percentage reduction in MASI score at the end of 12 weeks and pictures were also taken again Results The mean age of the patients was 29.23±6.58 years. Out of 100 patients, 81 were female and 19 were males with male to female ratio of 0.2:1. The mean percentage reduction of the modified MASI score at the end of 12 weeks was 41.43±14.56. Sixty three percent of patients had < 50% reduction while thirty seven percent had >50% reduction in modified MASI score after 12 weeks. In our study the efficacy was achieved in 37(37%) patients. Conclusion:This study concluded that the topical 5% tranexamic acid cream was effective in 37% of melasma patients in our study population (>50% reduction in baseline Modified MASI score) after 12 weeks.

References

Rodrigues M, Ayala-Cortés AS, Rodríguez-Arámbula A, Hynan LS, Pandya AG. Interpretability of the modified melasma area and severity index (mMASI). JAMA dermatology 2016;152(9):1051-2

Grimes P, Ijaz S, Nashawati R, Kwak D. New oral and topical approaches for the treatment of melasma. International journal of women's dermatology 2019;5(1):30-6. 3.

Basit H, Godse KV, Al Aboud AM. Melasma. Treasure Island (FL): StatPearls Publishing. 2019.

Melasma:a clinico-epidemiological study of 312cases.Indian J Dermatol2011;56:380-2

Padhi T, Pradhan S. Oral tranexamic acid with fluocinolone-based triple combination cream versus fluocinolone-based triple combination cream alone in melasma: An open labeled randomized comparative trial. Indian journal of dermatology 2015;60(5):520.

Wu S, Shi H, Wu H, et al. Treatment of melasma with oral administration of tranexamic acid. Aesthetic Plast Surg. 2012;36(4):964–970. doi: 10.1007/s00266-012-9899-9

Kanechorn Na Ayuthaya P, Niumphradit N, Manosroi A, Nakakes A. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. J Cosmet Laser Ther. 2012; 14(3):150–154.

Lake E. JAAD Game Changers: Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis. Journal of the American Academy of Dermatology 2019;80(3):833.

Khuraiya S, Kachhawa D, Chouhan B, Dua M, Rao P. A comparative study of topical 5% tranexamic acid and triple combination therapy for the treatment of melasma in Indian population. Pigment International 2019;6(1):18.

Del Rosario E, Florez-Pollack S, Zapata Jr L, Hernandez K, Tovar-Garza A, Rodrigues M, et al. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma. Journal of the American Academy of Dermatology 2018;78(2):363-9.

Janney MS, Subramaniyan R, Dabas R, Lal S, Das NM, Godara SK. A randomized controlled study comparing the efficacy of topical 5% tranexamic acid solution versus 3% hydroquinone cream in melasma. Journal of cutaneous and aesthetic surgery 2019;12(1):63.

Karen JK, Pomeranz MK. Skin changes and diseases in pregnancy.In:Wolff K,Goldsmith LA,Katz SI,GilchrestBA, PallerAS,Leffel DJ,editors.Dermatology in General Medicine,7th ed. New york:McGraw-Hill;2008.P.955-62

Nijor T. Treatment of melasma with tranexamic acid. Clin Res 1979;13(13):3129-31.

Sheth VM, Pandya AG. Melasma: a comprehensive update: part II. Journal of the American Academy of Dermatology 2011;65(4):699-714.

Singh R, Goyal S, Ahmed QR, Gupta N,Singh S. Effect of 82% lactic acid intreatment of melasma. Int Scholarly ResNotices. 2014;7:1-7.

ZhangL, Tan W-Q, Fang Q-Q, Zhao W-Y, Zhao Q-M, Gao J, et al. Tranexamic acid for adults with melasma: a systematic review and meta-analysis. BioMed research international 2018;2018.

Sarvjot V, Sharma S, Mishra S, Singh A.Melasma: A clinicopathological study of 43 cases. Indian J Pathol Microbiol 2009;52:357-59.

Iram Qazi, Naina K Dogra, Devraj Dogra, Melasma: A Clinical and Epidemiological Study.International Journal of Contemporary Medical Research 2017.

Tehranchinia Z, Saghi B, Rahimi H. Evaluation of therapeutic efficacy and safety of tranexamic acid local infiltration in combination with topical 4% hydroquinone cream compared to topical 4% hydroquinone cream alone in patients with melasma: a split-face study. Dermatology research and practice 2018;2018.

Padhi T, Pradhan S. Oral tranexamic acid with fluocinolone-based triple combination cream versus fluocinolone-based triple combination cream alone in melasma: An open labeled randomized comparative trial. Indian journal of dermatology 2015;60(5):520.

Taraz M, Niknam S, Ehsani AH. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies. Dermatologic therapy 2017;30(3):e12465.

Kim MS, Bang SH, Kim J-H, Shin H-J, Choi J-H, Chang SE. Tranexamic acid diminishes laser-induced melanogenesis. Annals of dermatology 2015;27(3):250.

Lee HC, Thng TGS, Goh CL. Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. Journal of the American Academy of Dermatology 2016;75(2):385-92.

Karn D, Kc S, Amatya A, Razouria E, Timalsina M. Oral tranexamic acid for the treatment of melasma. Kathmandu University Medical Journal 2012;10(4):40-3.

Elfar N, El-Maghraby G. Efficacy of intradermal injection of tranexamic acid, topical silymarin and glycolic acid peeling in treatment of melasma: A comparative study. J Clin Exp Dermatol Res 2015;6(280):2.

Downloads

Published

2023-10-12

How to Cite

1.
Ramzan F, Malik K, Bashir B, Naseer Z, Shehzad A, Malik L, Rashid T. Efficacy of 5% tranexamic acid in melasma. J Pak Assoc Dermatol [Internet]. 2023Oct.12 [cited 2024May22];33(4):1257-62. Available from: https://jpad.com.pk/index.php/jpad/article/view/2449

Issue

Section

Original Articles

Most read articles by the same author(s)

1 2 3 4 5 6 > >>